Kv3.3 subunits control presynaptic action potential waveform and neurotransmitter release at a central excitatory synapse
- University of Leicester, United Kingdom
- Ludwig-Maximilians-Universität München, Germany
- Istituto di Ricerca Pediatrica Citta'della Speranza, Italy
- University of Stirling, United Kingdom
Abstract
Kv3 potassium currents mediate rapid repolarization of action potentials (APs), supporting fast spikes and high repetition rates. Of the four Kv3 gene family members, Kv3.1 and Kv3.3 are highly expressed in the auditory brainstem and we exploited this to test for subunit-specific roles at the calyx of Held presynaptic terminal in the mouse. Deletion of Kv3.3 (but not Kv3.1) reduced presynaptic Kv3 channel immunolabelling, increased presynaptic AP duration and facilitated excitatory transmitter release; which in turn enhanced short-term depression during high frequency transmission. The response to sound was delayed in the Kv3.3KO, with higher spontaneous and lower evoked firing, thereby reducing signal-to-noise ratio. Computational modelling showed that the enhanced EPSC and short-term depression in the Kv3.3KO reflected increased vesicle release probability and accelerated activity-dependent vesicle replenishment. We conclude that Kv3.3 mediates fast repolarization for short precise APs, conserving transmission during sustained high-frequency activity at this glutamatergic excitatory synapse.
Data availability
Data generated in this study are included in the manuscript and supporting files. Source data files for each figure has been uploaded onto FigShare. Datasets Generated for the Ms "Kv3.3 subunits control presynaptic action potential waveform and neurotransmitter release at a central excitatory synapse" Authors: Ian D. Forsythe, Amy Richardson, Victoria Ciampani, Mihai Stancu, Kseniia Bondarenko, Sherylanne Newton, Joern Steinert, Nadia Pilati, Bruce Graham, Conny Kopp-Scheinpflug, 2022,https://figshare.com/s/9c0a07ed2fe5761cc281. The model code and associated data files are available at: Bruce Graham, 2021, https://github.com/bpgraham/CoH-Models
Article and author information
Author details
Funding
Biotechnology and Biological Sciences Research Council (R001154/1)
- Ian D Forsythe
Biotechnology and Biological Sciences Research Council (Case Award M016501)
- Ian D Forsythe
H2020 Health (ITN LISTEN 722098)
- Ian D Forsythe
Deutsche Forschungsgemeinschaft (DFG SFB870 A-10)
- Conny Kopp-Scheinpflug
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Animal experimentation: Experiments were conducted in accordance with the Animals (Scientific Procedures) Act UK 1986 and as revised by the European Directive 2010/63/EU on the protection of animals used for scientific purposes. All procedures were approved by national oversight bodies (UK Home Office, or Bavarian district government, ROB-55.2-2532.Vet_02-18-1183) and the local animal research ethics review committees. In vivo experiments were conducted under anaesthesia: with a subcutaneous injection of 0.01ml/g MMF (0.5mg/kg body weight Medetomidine, 5.0mg/kg body weight Midazolam and 0.05mg/kg body weight Fentanyl). Every effort was made to minimise suffering and at the end of each procedure the animal was humanely killed using an approved method.
Copyright
© 2022, Richardson et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 343
- downloads
-
- 24
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Kv3.3 subunits control presynaptic action potential waveform and neurotransmitter release at a central excitatory synapse
eLife 11:e75219.
https://doi.org/10.7554/eLife.75219
